HealthCure, LLC, a Detroit-based health care services company, recently closed on its second round of private equity funding. Physician’s Choice Laboratory Services (PCLS) of Charlotte, North Carolina, led the funding round. The Series B round was HealthCure’s second tranche of strategic funding, with the Series A round led by the Oakwood HealthCare Systems of Dearborn, Michigan.
HealthCure is a leader in the effort to reduce Healthcare Associated Infections (HAI), a major financial and health burden to the industry. There are over 2 million cases of HAI annually in the United States, resulting in about 100,000 deaths. The strategic funding validates the significance of HealthCure’s value proposition to the health care industry, and aligns the Company with two significant sources of financial capital, and industry expertise.
HealthCure’s comprehensive approach to HAI is unique, as the company focuses on facility assessment, innovative practices, the introduction of proprietary disinfecting products, and unique data compilation, which helps its clients reduce patient risk and bring down non-reimbursable costs. In addition to capital, PCLS brings a proprietary diagnostic assay, allowing HealthCure to rapidly assess, diagnose, and treat problem areas within a hospital.
Mark Arizmendi, HealthCure’s Managing Director, stated, “We are pleased to enter into an investment relationship with PCLS. They are a tremendous complement to the HealthCure business, and their scientific expertise, as well as their marketing prowess, will allow HealthCure to grow its core competency of assessing and treating facilities for HAI and help us advance our marketing efforts more rapidly and with greater effectiveness.”
Northwestern Capital Partners, LLC, of Charlotte, NC, and Chicago, IL, advised HealthCure on the financing. Northwestern Capital Partners is also an investor in the Company, along with Michael and Carlton Guthrie of Detroit, MI.
About HealthCure, LLC
HealthCure, LLC, is a Detroit-based company focused on reducing the risk of HAI in the healthcare system. HealthCure uses evidence-based methods and products to provide a virtual shield against the infectious agents that cause HAI. The Company manages complex and disparate data to develop and choose best in-class protocols to not only manage the hospital environment, but also to consult with hospitals to increase efficiency and bottom-line performance.
For additional Information, please contact:
Mark Arizmendi, CEO, Northwestern Capital Partners, LLC
Linda Ratliff, Manager Communications and Customer Service, HealthCure, LLC